The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients-Reference-Cited by-同舟云学术

The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients

Published:2019-11 Issue: Volume:36 Page:101415
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Noori Hossein^ORCID,Gheini Mohammad Reza,Rezaeimanesh Nasim,Saeedi Roghayyeh,Rezaei Aliabadi Hossein,Sahraian Mohammad Ali^ORCID,Naser Moghadasi Abdorreza^ORCID

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference25 articles.

1. Minimal neuropsychological assessment of Ms patients: a consensus approach;Benedict;Clin. Neuropsychol.,2002

2. Minimal neuropsychological assessment of MS patients: a consensus approach;Benedict;Clin. Neuropsychol.,2002

3. Benedict R.H. Brief visuospatial memory test–revised: professional manual: par; 1997.

4. Contributions to Neuropsychological Assessment: A Clinical Manual;Benton,1994

5. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial;Chan;Lancet Neurol.,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between sarcopenia and incident chronic lung disease in the general population: A longitudinal study based on CHARLS data;Experimental Gerontology;2023-09

2. The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects;Inflammopharmacology;2023-05-09

3. Metabolic syndrome parameters and multiple sclerosis disease outcomes: A Portuguese cross-sectional study;Multiple Sclerosis and Related Disorders;2023-01

4. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis;Multiple Sclerosis and Related Disorders;2023-01

5. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases;Molecular Neurodegeneration;2022-09-24